Jerome Wu

Executive Director

Novo Nordisk

Jerome is a growth architect and commercial leader at Novo Nordisk, where he leads the Ozempic^® brand, the type 2 diabetes therapy that became synonymous in its category and reshaped the healthcare conversations. 

Jerome brings more than 20 years of industry experience spanning science, operations, commercial strategy and executions. Known as a first-principle lateral thinker, he integrates insights and foresight with the macro-horizons to challenge the status quo and transform market landscapes. His unique breadth of experience enables him to drive growth with scientific integrity.

As a trusted and pragmatic leader, Jerome operates with intention and unity. He creates environments that prioritize progressive momentum over friction, elevates colleagues and teams, and inspires others to create meaningful impact.